Golden Seal 500mg 60 tabs
This is a practitioner-only product. Please arrange a telephone consultation with our health care practitioners to ensure this product is suitable for you.
Golden Seal (Hydrastis canadensis) is an endangered herb and as a result is very expensive and often substituted by other herbs.
The substituted herbs usually contain the substance berberine which provides the yellow colour, but they do not contain hydrastine which is unique to Golden
Seal. Only HPLC enables this differentiation to be made. MediHerb® tests each batch of Golden Seal raw material and finished product to ensure the claimed levels of hydrastine and berberine are present. Using HPLC, MediHerb® is able to clearly differentiate true Golden Seal from other berberine containing herbs. The table demonstrates the difference between the various berberine containing species. The top trace is an example of substitution where a professional product being sold in Australia as Indian Golden Seal matched the trace of Coptis chinensis.
Indications
- Golden Seal root is traditionally used in Western herbal medicine:
• to support healthy mucous tissue of the respiratory tract and reduce excess mucous
• to provide relief of mild inflammation of the mucous membranes of the respiratory and digestive tracts
• to stimulate gastric secretions, bile flow from the liver and promote healthy digestion
• to relieve symptoms of indigestion such as bloating and gas
Ingredients
Each tablet contains:
Hydrastis canadensis (Golden Seal) extract 277 mg
derived from root & rhizome dry 500 mg
Excipients
Calcium hydrogen phosphate dihydrate, colloidal anhydrous silica, croscarmellose sodium, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, silicon dioxide, sodium starch glycollate.
Warnings, Cautions and Contraindications
• Do not use if pregnant or likely to become pregnant.
• Berberine may reinforce the effects of other drugs which displace the protein binding of bilirubin.
• Contraindicated during pregnancy and lactation.
• Caution in patients taking midazolam.
• If diarrhoea persists for more than 6 hours in infants under 6 months, 12 hours in children under 3 years, 24 hours in children aged 3 – 6 years or 48 hours in adults and children over 6 years, seek medical advice.
• Until definitive research is available, do not use in jaundiced neonates.
• Discontinue 7 days prior to general anaesthesia.
If patient symptoms persist, seek additional professional advice.
Allergen Information
No added: Gluten, soya bean, milk, lactose, peanuts, tree nuts, fish, crustacea, corn, egg, sesame seeds or artificial colours